MYDGF deficiency, on the other hand, exacerbates MC in podocytes in DKD, suggesting that MYDGF may be an attractive therapeutic target for DKD (He et al. 2020; Zhan et al. 2022). The gene discussed is MYDGF; the disease is diabetic kidney disease.